πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 1,015 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 7491802

Anti-BAMBI antibody and diagnostic or remedy for colon cancer and liver cancer

Takeda Pharmaceutical Company Limited Β· Granted Tue Feb 17 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 12 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7482351

4-pyrimidineamine compounds and their uses as anti-proliferative agents

Rigel Pharmaceuticals, Inc. Β· Granted Tue Jan 27 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 22 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7479484

Peptides and peptidomimetics having immune-modulating, anti-inflammatory, and anti-viral a

Takeda Pharmaceutical Company Limited Β· Granted Tue Jan 20 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 15 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7476657

Peptides and peptidomimetics having anti-proliferative activity and/or that augment nuclei

Takeda Pharmaceutical Company Limited Β· Granted Tue Jan 13 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 08 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7473525

Compositions and methods for inhibiting expression of anti-apoptotic genes

Alnylam Europe AG Β· Granted Tue Jan 06 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 01 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7470775

Anti-CD30 stalk and anti-CD30 antibodies suitable for use in immunotoxins

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Dec 30 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 25 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7465449

Anti-Ξ±vΞ²6 antibodies

The Regents of the University of California Β· Granted Tue Dec 16 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 11 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7449182

Therapeutic combination of a VEGF antagonist and anti-hypertensive agent

REGENERON PHARMACEUTICALS, INC. Β· Granted Tue Nov 11 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 06 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7427496

Anti-cancer compounds

The Regents of the University of Colorado Β· Granted Tue Sep 23 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 18 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7423142

Compositions and methods for inhibiting expression of anti-apoptotic genes

Alnylam Pharmaceuticals, Inc. Β· Granted Tue Sep 09 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 04 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7388089

Anti-arthropod vector vaccines method of selecting and uses thereof

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Jun 17 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 12 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7384909

Anti-viral treatment methods using phosphatidylethanolamine-binding peptides linked to ant

The Board of Regents of the University of Texas System Β· Granted Tue Jun 10 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 05 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7378386

Anti-viral treatment methods using phosphatidylethanolamine-binding peptide derivatives

The Board of Regents of the University of Texas System Β· Granted Tue May 27 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 22 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7358085

Anti-angiogenic methods and compositions

Sangamo Biosciences, Inc. Β· Granted Tue Apr 15 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 10 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7355012

Mutated anti-CD22 antibodies with increased affinity to CD22-expressing leukemia cells

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Apr 08 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 03 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7354579

Method of treating cancer with a VEGF antagonist and an anti-proliferative agent

REGENERON PHARMACEUTICALS, INC. Β· Granted Tue Apr 08 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 03 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7354581

Therapeutic combination of a VEGF antagonist and anti-hypertensive agent

REGENERON PHARMACEUTICALS, INC. Β· Granted Tue Apr 08 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 03 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7326695

Anti-bacterial agents based upon oxoanion binding

THE TRUSTEES OF PRINCETON UNIVERSITY Β· Granted Tue Feb 05 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 31 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7319000

Compositions and methods for eliciting immune or anti-infective responses

The Board of Regents of the University of Texas System Β· Granted Tue Jan 15 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 10 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7303751

Anti-plasmodium compositions and methods of use

The Government of the United States of American, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Dec 04 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 29 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7282205

Anti-hepatitis A virus antibodies

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Oct 16 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 11 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7276227

Obligate domain-swapped dimer of cyanovirin with enhanced anti-viral activity

UNITED STATES OF AMERICA, AS REPRESENTED BY SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES Β· Granted Tue Oct 02 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 27 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7276643

Transgenic animals, cell lines derived therefrom, and methods for screening for anti-amylo

The Regents of the University of California Β· Granted Tue Oct 02 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 27 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7264804

Kits for detecting anti-SIRS antibodies

Regents of the University of Minnesota Β· Granted Tue Sep 04 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 30 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted